Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
119,547,665
-
Share change
-
+4,508,409
-
Total reported value
-
$4,109,936,889
-
Put/Call ratio
-
148%
-
Price per share
-
$34.38
-
Number of holders
-
215
-
Value change
-
+$169,511,200
-
Number of buys
-
114
-
Number of sells
-
100
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q1 2017
As of 31 Mar 2017 ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) had 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 119,547,665 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., OppenheimerFunds, Inc., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and WADDELL & REED FINANCIAL INC.
This table shows 215 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.